References
1. Topilsky, Y., et al., Clinical presentation and outcome of tricuspid regurgitation in patients with systolic dysfunction. European Heart Journal, 2018. 39 (39): p. 3584-3592.
2. Topilsky, Y., et al., Burden of Tricuspid Regurgitation in Patients Diagnosed in the Community Setting. Jacc: Cardiovascular Imaging, 2019. 12 (3): p. 433-442.
3. Nath, J., E. Foster, and P.A. Heidenreich, Impact of tricuspid regurgitation on long-term survival. Journal of the American College of Cardiology, 2004. 43 (3): p. 405-9.
4. Axtell, A.L., et al., Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation. Journal of the American College of Cardiology, 2019. 74 (6): p. 715-725.
5. Kilic, A., et al., Trends and outcomes of tricuspid valve surgery in North America: an analysis of more than 50,000 patients from the Society of Thoracic Surgeons database. Annals of Thoracic Surgery, 2013. 96 (5): p. 1546-52; discussion 1552.
6. Asmarats, L., et al., Transcatheter Tricuspid Valve Interventions: Landscape, Challenges, and Future Directions. Journal of the American College of Cardiology, 2018. 71 (25): p. 2935-2956.
7. Fam, N.P., et al., Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Multicenter, Observational, First-in-Human Experience. Jacc: Cardiovascular Interventions, 2021.14 (5): p. 501-511.
8. Fam, N.P., et al., Transfemoral Transcatheter Tricuspid Valve Replacement. Jacc: Cardiovascular Interventions, 2020. 13 (10): p. e93-e94.
9. Kodali, S.K., TRISCEND: six month outcomes of transfemoral triscupid valve replacement in patients with tricuspid regurgitation.TCT proceedings, 2021.
10. Hale, B., Bradley, DJ, Zampi, JD, Whiteside, W, Cunnane, R,First-in-human combined transcatheter tricuspid valve implantation with leadless VDD pacemaker via left internal jugular approach.HeartRhythm Case Reports, 2021: p. 1-5.
11. Roberts, P.R., et al., A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry.Heart Rhythm, 2017. 14 (9): p. 1375-1379.
12. Piccini, J.P., et al., Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker. JAMA Cardiology, 2021. 6 (10): p. 1187-1195.
13. Reynolds, D., et al., A Leadless Intracardiac Transcatheter Pacing System. New England Journal of Medicine, 2016. 374 (6): p. 533-41.
14. El-Chami, M.F., et al., Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control. Heart Rhythm, 2018. 15 (12): p. 1800-1807.
15. Steinwender, C., et al., Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker: Results From the MARVEL 2 Study. JACC. Clinical Electrophysiology, 2020. 6 (1): p. 94-106.
16. Kolek, M.J., G.H. Crossley, and C.R. Ellis, Implantation of a MICRA Leadless Pacemaker Via Right Internal Jugular Vein. JACC. Clinical Electrophysiology, 2018. 4 (3): p. 420-421.
17. Morani, G., et al., Leadless pacemaker through tricuspid bioprosthetic valve: Early experience. Journal of Arrhythmia, 2021.37 (2): p. 414-417.